So here we are in single digits again. Without any news likely on FDA for months (or longer). No distributors achieving any major sales it seems with FIVE2, and minimal sales of Convivo with Zeiss.
It would seem likely a trading range back to the 0.05 - 0.09 levels. If anyone can come up with a more positive 6-12 month outlook, I'd love to hear the reasoning.
Add to My Watchlist
What is My Watchlist?
